These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression. Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101 [TBL] [Abstract][Full Text] [Related]
24. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533 [TBL] [Abstract][Full Text] [Related]
25. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer]. Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290 [TBL] [Abstract][Full Text] [Related]
26. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Modok S; Mellor HR; Callaghan R Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355 [TBL] [Abstract][Full Text] [Related]
28. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613 [TBL] [Abstract][Full Text] [Related]
29. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Marques DS; Sandrini JZ; Boyle RT; Marins LF; Trindade GS Leuk Res; 2010 Jun; 34(6):757-62. PubMed ID: 19969351 [TBL] [Abstract][Full Text] [Related]
30. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Allen JD; Brinkhuis RF; van Deemter L; Wijnholds J; Schinkel AH Cancer Res; 2000 Oct; 60(20):5761-6. PubMed ID: 11059771 [TBL] [Abstract][Full Text] [Related]
31. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines. Tomiyasu H; Watanabe M; Sugita K; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H Anticancer Res; 2013 Dec; 33(12):5317-23. PubMed ID: 24324065 [TBL] [Abstract][Full Text] [Related]
32. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594 [TBL] [Abstract][Full Text] [Related]
33. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. van Veen HW; Callaghan R; Soceneantu L; Sardini A; Konings WN; Higgins CF Nature; 1998 Jan; 391(6664):291-5. PubMed ID: 9440694 [TBL] [Abstract][Full Text] [Related]
34. Drug resistance molecules: lessons from oncology. Scheffer GL; Scheper RJ Novartis Found Symp; 2002; 243():19-31; discussion 31-7, 180-5. PubMed ID: 11990777 [TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein in adult hematologic malignancies. Marie JP Hematol Oncol Clin North Am; 1995 Apr; 9(2):239-49. PubMed ID: 7642463 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms responsible for therapy resistance of acute myelogenous leukemia (AML). Köhler T; Eller J; Leiblein S; Lassner D; Helbig W; Remke H; Wagner O Int J Clin Pharmacol Ther; 1998 Feb; 36(2):97-8. PubMed ID: 9520156 [No Abstract] [Full Text] [Related]
37. Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Cascorbi I; Haenisch S Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922 [TBL] [Abstract][Full Text] [Related]
38. Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy. Kim DW; Lee SK; Chu K; Jang IJ; Yu KS; Cho JY; Kim SJ Epilepsy Res; 2009 Mar; 84(1):86-90. PubMed ID: 19167193 [TBL] [Abstract][Full Text] [Related]
39. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts. Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695 [TBL] [Abstract][Full Text] [Related]
40. [Role of ABCB1 and ABCG2 in the multidrug resistance of hypopharyngeal carcinoma FaDu cell line]. MA JK; LU SM; YU L; TIAN JJ; LI JF; WANG HB; XU W Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):305-10. PubMed ID: 22800348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]